Projects

A randomized controlled trial to evaluate the effectiveness, safety and tolerability of psilocybin, in comparison to standard treatment, for young adults with severe anorexia nervosa. The study will involve 40 participants and is led by Pouya Movahed Rad, Senior researcher, at Lund University.

Learn more

A project at Karolinska Institutet to analyze data from two clinical trials, featuring more than 120 patients, to better understand the therapeutic framework needed for safe and effective administration of psilocybin for depression.

Learn more

Norrsken Mind is co-funding a planned RCT at the University of Copenhagen to evaluate the short- and long-term effects of psilocybin for depression when administered within a psychotherapeutic framework versus a medical support model.

Learn more

Researchers at Karolinska Institutet investigates the cognitive and neurobiological changes associated with psilocybin-assisted therapy, which may offer insights into the neurobiology of major depressive disorder and the therapeutic mechanisms of psilocybin.

Learn more

Norrsken Mind funded the first Swedish clinical trial using a psilocybin-assisted therapy protocol. At Karolinska Institutet, the study investigates the effects of psilocybin on symptoms of depression and synaptic density.

Learn more

Norrsken Mind is funding a research project to produce a comprehensive report on reimbursement pathways for psychedelic treatments in Europe. The project is led by Floris Wolswijk, founder of Blossom (a psychedelic science and insight platform), and Martin Gisby, independent healthcare consultant with over 15 years of experience.

Learn more

Norrsken Mind has granted partial funding to a study under planning at Umeå University to investigate MDMA-assisted psychotherapy as a treatment for depression in young adults (aged 18-25).

Learn more

Norrsken Mind is funding a project at Karolinska Institutet to investigate the genetic and environmental contributions to psychiatric risks and benefits of psychedelic use in vulnerable populations.

Learn more

An epidemiological research program at Karolinska Institutet by Otto Simonsson, PhD, and Walter Osika, MD PhD, focused on investigating the link between the use of classic psychedelics and different somatic disorders

Learn more

A project investigating the adolescent and young adult use and experience of psychedelics in two different and natural settings through survey, longitudinal observation, and in-depth interviews.

Learn more

The Nordic Psychedelic Science Conference (NPSC) in Oslo, Norway, on the May 19-20th, 2022.

Learn more